Weidinger, Stephan, Andrew Pink, Juan Francisco, Azra Kurbasic, Christina Olsen, Andreas Vilsbøll, and Marjolein de Bruin Weller. 2020. “Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients With Moderate-To-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 4 (6):s100. https://doi.org/10.25251/skin.4.supp.100.